|
⚲
|
| Keyboard |
| Friedberg Ezra M
✚
|
|
|---|---|
| CIK # | 0001679440 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001679440] | |
| 4 | [0001679440] | |
| SC 13D | [0001679440] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Friedberg Ezra M | Chromocell Therapeutics Corp | [2024-02-26] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Channel Therapeutics Corp | |
| Friedberg Ezra M | |
| Balmoral Financial Group LLC | |
| Humanigen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-11-25 | Sell | 2,000 | $28.14 | 56,280 |
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-11-25 | Sell | 1 | $28.50 | 28 |
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-11-25 | Sell | 2,000 | $28.01 | 56,020 |
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-11-25 | Sell | 5,999 | $28.00 | 167,972 |
|
Channel Therapeutics Corp PTHS
Restricted Stock Units · derivative
|
2025-07-02 | Grant | 19,108 | ||
|
Channel Therapeutics Corp PTHS
Stock Option · derivative
|
2025-07-02 | Grant | 58,230 | ||
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Buy | 40,000 | $0.00 | |
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-07-01 | Conversion | 40,000 | $10.00 | 400,000 |
|
Channel Therapeutics Corp PTHS
Common Stock
|
2025-07-01 | Conversion | 40,000 | $10.00 | 400,000 |
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Buy | 40,000 | $0.00 | |
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Conversion | 40,000 | $0.00 | |
|
Channel Therapeutics Corp PTHS
Series A Convertible Preferred Stock · derivative
|
2025-07-01 | Conversion | 40,000 | $0.00 | |
|
Channel Therapeutics Corp CHRO
Restricted Stock Units · derivative
|
2024-11-13 | Grant | 24,533 | ||
|
Channel Therapeutics Corp CHRO
Restricted Stock Units · derivative
|
2024-06-14 | Grant | 64,498 | ||
|
Channel Therapeutics Corp CHRO
Secured Convertible Promissory Note · derivative
|
2024-02-21 | Conversion | 65,513.61 | ||
|
Channel Therapeutics Corp CHRO
Common Stock
|
2024-02-21 | Option exercise | 13,649 | $4.80 | 65,515 |
|
Channel Therapeutics Corp CHRO
Common Stock
|
2024-02-21 | Option exercise | 6,992 | $4.80 | 33,562 |
|
Channel Therapeutics Corp CHRO
Secured Convertible Promissory Note · derivative
|
2024-02-21 | Conversion | 33,136 | ||
|
Humanigen Inc KBIO
Stock Option (right to buy) · derivative
|
2016-09-13 | Grant | 100,000 | $0.00 |